using mrd as an endpoint in clinical trials
Published 4 years ago • 49 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:31
mrd as an endpoint in clinical trials
-
2:17
opinion: value of mrd as an endpoint in hem-onc clinical trials
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
2:41
an overview of the latest advances in hematology
-
1:46
standardization mrd monitoring in clinical trials
-
1:26
the current role of mrd in aml and challenges with implementing this in clinical practice
-
2:35
an update on mrd assessment and novel techniques used in the treatment of hematological malignancies
-
3:27
the role of mrd in aml regulatory decision making
-
2:37
evidence supporting mrd-guided treatment breaks in mm
-
1:37
mrd in myeloma
-
1:33
tourmaline-mm3: undetectable mrd as an endpoint for maintenance therapy
-
2:25
the clinical use of mrd in cll and challenges in this space
-
1:45
role for mrd assessment in al amyloidosis?
-
15:21
mrd assessment and the treatment of patients in the 'real world'
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:05
mrd in aml clinical practice
-
1:39
an insight into mrd monitoring and mrd-driven treatment in aml
-
1:09
taking mrd from trials to the clinic